Specializing in the areas of Biotechnology and Hospitality, Mill Creek Life Sciences provides crucial tools and technologies to support the development and application of cellular and biologic therapeutics. The company recently received a $100.00K grant investment from Regenerative Medicine Minnesota on 18 June 2019. With its focus on quality, innovation, and customer service, Mill Creek Life Sciences is well-poised to continue its impactful contributions to the field of regenerative medicine.
General Information
BounceWatch is an independent company data service, not affiliated with Mill Creek Life Sciences. To contact Mill Creek Life Sciences, visit millcreekls.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Mill Creek Life Sciences compare?
A PDF of Mill Creek Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Mill Creek Life Sciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Mill Creek Life Sciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Mill Creek Life Sciences
Business keywords: Regenerative Medicine, Biotechnology, Cellular Therapy, Biologic Therapeutics, Mayo Clinic, Innovation, Medical Technology, Patient Care, Research and Development, Life Sciences
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $100.00K | 1 |
Regenerative Medicine Minnesota
|
18 Jun 2019 |
| Seed Round | $625.00K | - |
|
17 Sep 2012 |
| Seed Round | $100.00K | - |
|
15 Sep 2011 |
Mill Creek Life Sciences Alternatives & Competitors
View All AlternativesDeveloping innovative precision therapies for the treatment of inflammatory and fibrotic diseases
Personalised Cancer Intelligence
We are dedicated to develop novel stem cell therapies to treat chronic diseases
FAQ About Mill Creek Life Sciences
Source: BounceWatch company record for Mill Creek Life Sciences, https://bouncewatch.com/company/mill-creek-life-sciences, updated 24 October 2024. When citing, please name BounceWatch and link this page.